These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: A systemic review. Riaz M; Abbas M; Rasool G; Baig IS; Mahmood Z; Munir N; Mahmood Tahir I; Ali Shah SM; Akram M Int J Immunopathol Pharmacol; 2022; 36():3946320221096909. PubMed ID: 35452334 [TBL] [Abstract][Full Text] [Related]
6. An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines. Ekwattanakit S; Hantaweepant C; Khuhapinant A; Siritanaratkul N; Viprakasit V Sci Rep; 2021 Jun; 11(1):13283. PubMed ID: 34168246 [TBL] [Abstract][Full Text] [Related]
7. Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. Karimi M; Darzi H; Yavarian M J Pediatr Hematol Oncol; 2005 Jul; 27(7):380-5. PubMed ID: 16012328 [TBL] [Abstract][Full Text] [Related]
8. Red blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence-based guidelines. Goss C; Giardina P; Degtyaryova D; Kleinert D; Sheth S; Cushing M Transfusion; 2014 Jul; 54(7):1773-81. PubMed ID: 24611697 [TBL] [Abstract][Full Text] [Related]
9. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand. Chuncharunee S; Teawtrakul N; Siritanaratkul N; Chueamuangphan N PLoS One; 2019; 14(3):e0214148. PubMed ID: 30893381 [TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
11. Thalassemia: Common Clinical Queries in Management. Lal A; Bansal D Indian J Pediatr; 2020 Jan; 87(1):75-81. PubMed ID: 31620986 [TBL] [Abstract][Full Text] [Related]
12. Thalassemia in Pakistan. Khaliq S Hemoglobin; 2022 Jan; 46(1):12-14. PubMed ID: 35950582 [TBL] [Abstract][Full Text] [Related]
13. Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand. Teawtrakul N; Songdej D; Hantaweepant C; Tantiworawit A; Lauhasurayotin S; Torcharus K; Sripornsawan P; Sutcharitchan P; Surapolchai P; Komvilaisak P; Saengboon S; Pongtanakul B; Charoenkwan P; Transfusion; 2022 Oct; 62(10):2039-2047. PubMed ID: 35986658 [TBL] [Abstract][Full Text] [Related]
14. Critical Care Network in the State of Qatar. Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205 [TBL] [Abstract][Full Text] [Related]
15. HLA class I antibodies in thalassemic patients. Nathalang O; Torcharus K; Chuansumrit A; Punyaprasiddhi P; Sriphaisal T; Tatsumi N Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):801-4. PubMed ID: 10772568 [TBL] [Abstract][Full Text] [Related]
16. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand. Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298 [TBL] [Abstract][Full Text] [Related]
17. Improving care for thalassemia patients in line with best practice standards at a tertiary referral cancer care center. Bongay L; Kynoch K JBI Evid Implement; 2022 Jun; 20(2):128-133. PubMed ID: 33852496 [TBL] [Abstract][Full Text] [Related]
18. Transfusion practices and complications in thalassemia. Lal A; Wong TE; Andrews J; Balasa VV; Chung JH; Forester CM; Ikeda AK; Keel SB; Pagano MB; Puthenveetil G; Shah SJ; Yu JC; Vichinsky EP Transfusion; 2018 Dec; 58(12):2826-2835. PubMed ID: 30260477 [TBL] [Abstract][Full Text] [Related]
19. HTLV-I antibody screening in donated blood and thalassemic patients. Chiewsilp P; Iamsilp W; Hathirat P J Med Assoc Thai; 1993 Oct; 76 Suppl 2():103-5. PubMed ID: 7822977 [TBL] [Abstract][Full Text] [Related]
20. Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program. Sruamsiri R; Chaiyakunapruk N; Pakakasama S; Sirireung S; Sripaiboonkij N; Bunworasate U; Hongeng S BMC Health Serv Res; 2013 Feb; 13():45. PubMed ID: 23379888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]